In vitro and in vivo effects of digoxin derivatives on promastigotes and amastigotes of Leishmania infantum

References

• WHO. 2020. https://www.who.int/health-topics/leishmaniasis.
   Google Scholar
• Lukes J, Mauricio IL, Schonian G, et al. Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc Natl Acad Sci USA. 2007;104:9375–9380. doi:10.1073/pnas.0703678104
   PubMed Web of Science ®Google Scholar
• Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol. 2014;6:147–154. doi:10.2147/CLEP.S44267
   PubMed Web of Science ®Google Scholar
• Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27:305–318. doi:10.1016/j.cimid.2004.03.004
   PubMed Web of Science ®Google Scholar
• den Boer M, Argaw D, Jannin J, et al. Leishmaniasis impact and treatment access. Clin Microbiol Infect. 2011;17:1471–1477. doi:10.1111/j.1469-0691.2011.03635.x
   PubMed Web of Science ®Google Scholar
• Dorlo TP, Eggelte TA, Schoone GJ, et al. A poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appeal. PLoS Negl Trop Dis. 2012;6:e1544. doi:10.1371/journal.pntd.0001544
   PubMed Web of Science ®Google Scholar
• Singh N, Kumar M, Singh RK. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pac J Trop Med. 2012;5:485–497. doi:10.1016/S1995-7645(12)60084-4
   PubMed Web of Science ®Google Scholar
• Sundar S, More DK, Singh MK, et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis. 2000;31:1104–1107. doi:10.1086/318121
   PubMed Web of Science ®Google Scholar
• Ponte-Sucre A, Gamarro F, Dujardin JC, et al. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl Trop Dis. 2017;11:e0006052. doi:10.1371/journal.pntd.0006052
   PubMed Web of Science ®Google Scholar
• Bagher Khadem Erfan M, Mohebali M, Kazemi-Rad E, et al. Downregulation of calcineurin gene Is associated with glucantime® resistance in Leishmania infantum. Iran J Parasitol. 2013;8:359–366.
   PubMed Web of Science ®Google Scholar
• Singh J, Khan MI, Singh Yadav SP, et al. L-Asparaginase of Leishmania donovani: metabolic target and its role in amphotericin B resistance. Int J Parasitol Drugs Drug Resist. 2017;7:337–349. doi:10.1016/j.ijpddr.2017.09.003
   PubMed Web of Science ®Google Scholar
• Costa Filho AVdL, Sampaio RNR. Estudo comparativo entre miltefosina oral e antimoniato de N-metil glucamina parenteral no tratamento da leishmaniose experimental causada por Leishmania (Leishmania) amazonensis. Rev Soc Bras Med Trop. 2008;41:424–427. doi:10.1590/S0037-86822008000400022
   PubMedGoogle Scholar
• Mishra BB, Kale RR, Singh RK, et al. Alkaloids: future prospective to combat leishmaniasis. Fitoterapia. 2009;80:81–90. doi:10.1016/j.fitote.2008.10.009
   PubMed Web of Science ®Google Scholar
• Ambrosy AP, Butler J, Ahmed A, et al. The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions. J Am Coll Cardiol. 2014;63:1823–1832. doi:10.1016/j.jacc.2014.01.051
   PubMed Web of Science ®Google Scholar
• Hauptman PJ, Kelly RA. Digitalis. Circulation. 1999;99:1265–1270. doi:10.1161/01.CIR.99.9.1265
   PubMed Web of Science ®Google Scholar
• Ewy GA. Digoxin: the art and science. Am J Med. 2015;128:1272–1274. doi:10.1016/j.amjmed.2015.06.016
   PubMed Web of Science ®Google Scholar
• Ziff OJ, Lane DA, Samra M, et al. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ. 2015;351:h4451. doi:10.1136/bmj.h4451
   PubMed Web of Science ®Google Scholar
• Stucky MA, Goldberger ZD. Digoxin: its role in contemporary medicine. Postgrad Med J. 2015;91:514–518. doi:10.1136/postgradmedj-2014-132937
   PubMed Web of Science ®Google Scholar
• Karasneh RA, Murray LJ, Mc Menamin UC, et al. Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study. Breast Cancer Res Treat. 2015;151:661–669. doi:10.1007/s10549-015-3417-0
   PubMed Web of Science ®Google Scholar
• Ashbrook AW, Lentscher AJ, Zamora PF, et al. Antagonism of the sodium-potassium ATPase impairs chikungunya virus infection. mBio. 2016;7. doi:10.1128/mBio.00693-16
   PubMed Web of Science ®Google Scholar
• Wong RW, Balachandran A, Ostrowski MA, et al. Digoxin suppresses HIV-1 replication by altering viral RNA processing. PLoS Pathog. 2013;9:e1003241. doi:10.1371/journal.ppat.1003241
   PubMed Web of Science ®Google Scholar
• Freitas CS, Lage DP, Oliveira-da-Silva JA, et al. In vitro and in vivo antileishmanial activity of beta-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis. Parasite. 2021a;28:38. doi:10.1051/parasite/2021036
   PubMedGoogle Scholar
• Freitas CS, Oliveira-da-Silva JA, Lage DP, et al. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Parasitol Res. 2021b;120:321–335. doi:10.1007/s00436-020-06971-2
   PubMed Web of Science ®Google Scholar
• Jacob PL, Leite JA, Alves AK, et al. Immunomodulatory activity of ouabain in Leishmania leishmania amazonensis-infected Swiss mice. Parasitol Res. 2013;112:1313–1321. doi:10.1007/s00436-012-3146-9
   PubMed Web of Science ®Google Scholar
• Hartley MA, Bourreau E, Rossi M, et al. Leishmaniavirus-dependent metastatic Leishmaniasis is prevented by blocking IL-17A. PLoS Pathog. 2016;12:e1005852. doi:10.1371/journal.ppat.1005852
   PubMed Web of Science ®Google Scholar
• Alves SL, Paixao N, Ferreira LG, et al. Gamma-benzylidene digoxin derivatives synthesis and molecular modeling: evaluation of anticancer and the Na,K-ATPase activity effect. Bioorg Med Chem. 2015;23:4397–4404. doi:10.1016/j.bmc.2015.06.028
   PubMed Web of Science ®Google Scholar
• Pessoa MTC, Alves SLG, Taranto AG, et al. Selectivity analyses of gamma-benzylidene digoxin derivatives to different Na,K-ATPase alpha isoforms: a molecular docking approach. J Enzyme Inhib Med Chem. 2018;33:85–97. doi:10.1080/14756366.2017.1380637
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63. doi:10.1016/0022-1759(83)90303-4
   PubMed Web of Science ®Google Scholar
• Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett. 1985;24:119–124. doi:10.1016/0378-4274(85)90046-3
   PubMed Web of Science ®Google Scholar
• Reis de Sa LF, Toledo FT, de Sousa BA, et al. Synthetic organotelluride compounds induce the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisiae. BMC Microbiol. 2014;14:201. doi:10.1186/s12866-014-0201-y
   PubMed Web of Science ®Google Scholar
• Chang KP. Human cutaneous Leishmania in a mouse macrophage line: propagation and isolation of intracellular parasites. Science. 1980;209:1240–1242. doi:10.1126/science.7403880
   PubMed Web of Science ®Google Scholar
• Azevedo-Martins AC, Machado AC, Klein CC, et al. Mitochondrial respiration and genomic analysis provide insight into the influence of the symbiotic bacterium on host trypanosomatid oxygen consumption. Parasitology. 2015;142:352–362. doi:10.1017/S0031182014001139
   PubMed Web of Science ®Google Scholar
• Marinho FA, Goncalves KC, Oliveira SS, et al. The calpain inhibitor MDL28170 induces the expression of apoptotic markers in Leishmania amazonensis promastigotes. PLoS One. 2014;9:e87659. doi:10.1371/journal.pone.0087659.
   PubMed Web of Science ®Google Scholar
• Freitas EO, Nico D, Alves-Silva MV, et al. Immucillins ImmA and ImmH are effective and non-toxic in the treatment of experimental visceral leishmaniasis. PLoS Negl Trop Dis. 2015;9(12):e0004297. doi:10.1371/journal.pntd.0004297
   PubMed Web of Science ®Google Scholar
• Brasil PF, de Freitas JA, Barreto ALS, et al. Antiproliferative and ultrastructural effects of phenethylamine derivatives on promastigotes and amastigotes of Leishmania (Leishmania) infantum chagasi. Parasitol Int. 2017;66:47–55. doi:10.1016/j.parint.2016.11.010
   PubMed Web of Science ®Google Scholar
• Gomes DCO, Souza B, Schwedersky RP, et al. Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis. Microbes Infect. 2022;24:104884. doi:10.1016/j.micinf.2021.104884
   PubMed Web of Science ®Google Scholar
• PAHO. (2020). General information: Leishmaniasis.
   Google Scholar
• Bagrov AY, Shapiro JI. Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat Clin Pract Nephrol. 2008;4:378–392. doi:10.1038/ncpneph0848
   PubMedGoogle Scholar
• Tröhler U. Withering's 1785 appeal for caution when reporting on a new medicine. J R Soc Med. 2007;100:155–156. doi:10.1177/014107680710000316
   PubMed Web of Science ®Google Scholar
• Pincus M. Management of digoxin toxicity. Aust Prescr. 2016;39:18–20. doi:10.18773/austprescr.2016.006
   PubMed Web of Science ®Google Scholar
• MacLeod-Glover N, Mink M, Yarema M, et al. Digoxin toxicity: case for retiring its use in elderly patients? Can Fam Physician. 2016;62:223–228.
   PubMed Web of Science ®Google Scholar
• Rocha SC, Pessoa MT, Neves LD, et al. 21-Benzylidene digoxin: a proapoptotic cardenolide of cancer cells that up-regulates Na,K-ATPase and epithelial tight junctions. PLoS One. 2014;9:e108776. doi:10.1371/journal.pone.0108776
   PubMed Web of Science ®Google Scholar
• Huh JR, Leung MW, Huang P, et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity. Nature. 2011;472:486–490. doi:10.1038/nature09978
   PubMed Web of Science ®Google Scholar
• Katz A, Tal DM, Heller D, et al. Digoxin derivatives with selectivity for the alpha2beta3 isoform of Na,K-ATPase potently reduce intraocular pressure. Proc Natl Acad Sci USA. 2015;112:13723–13728. doi:10.1073/pnas.1514569112
   PubMed Web of Science ®Google Scholar
• Kumari N, Singh S, Kumari V, et al. Ouabain potentiates the antimicrobial activity of aminoglycosides against Staphylococcus aureus. BMC Complement Altern Med. 2019;19:119. doi:10.1186/s12906-019-2532-6
   PubMed Web of Science ®Google Scholar
• Katsuno K, Burrows JN, Duncan K, et al. Hit and lead criteria in drug discovery for infectious diseases of the developing world. Nat Rev Drug Discov. 2015;14:751–758. doi:10.1038/nrd4683
   PubMed Web of Science ®Google Scholar
• Martins LF, Mesquita JT, Pinto EG, et al. Analogues of marine guanidine alkaloids are in vitro effective against Trypanosoma cruzi and selectively eliminate Leishmania (L.) infantum intracellular amastigotes. J Nat Prod. 2016;79:2202–2210. doi:10.1021/acs.jnatprod.6b00256
   PubMed Web of Science ®Google Scholar
• Santhamma KR, Bhaduri A. Characterization of the respiratory chain of Leishmania donovani promastigotes. Mol Biochem Parasitol. 1995;75:43–53. doi:10.1016/0166-6851(95)02510-3
   PubMed Web of Science ®Google Scholar
• Melby PC, Chandrasekar B, Zhao W, et al. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J Immunol. 2001;166:1912–1920. doi:10.4049/jimmunol.166.3.1912
   PubMed Web of Science ®Google Scholar
• Saini S, Rai AK. Hamster, a close model for visceral leishmaniasis: opportunities and challenges. Parasite Immunol. 2020;42:e12768. doi:10.1111/pim.12768
   PubMed Web of Science ®Google Scholar
• Barros-Goncalves TD, Saavedra AF, Silva-Couto LD, et al. Increased levels of cortisol are associated with the severity of experimental visceral leishmaniasis in a Leishmania (L.) infantum-hamster model. PLoS Negl Trop Dis. 2021;15:e0009987. doi:10.1371/journal.pntd.0009987
   PubMed Web of Science ®Google Scholar
• Henao HH, Osorio Y, Saravia NG, et al. Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application. Biomedica. 2004;24:393–402. doi:10.7705/biomedica.v24i4.1289
   PubMedGoogle Scholar
• Kato KC, Morais-Teixeira E, Reis PG, et al. Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid. Antimicrob Agents Chemother. 2014;58:481–488. doi:10.1128/AAC.01499-13
   PubMed Web of Science ®Google Scholar